Target intelligence / Profile preview

Septin

Target
Septin
Molecular classification
Small GTPase, Cytoskeletal protein, Filament-forming protein, P-loop NTPase family, Scaffold protein
01

Overview

Septins are a conserved family of GTP-binding proteins found in nearly all eukaryotes except plants. They are classified as small GTPases and can self-assemble into hetero-oligomeric complexes that form filaments, rings, and other higher-order structures within cells. Septins act as cytoskeletal elements, particularly in cell division (cytokinesis), where they create scaffolds and diffusion barriers at specific cellular regions, thus regulating cell compartmentalization and polarity. They interact with cell membranes, actin filaments, and microtubules, and serve as attachment sites for other proteins, contributing to numerous cellular processes such as morphogenesis, membrane remodeling, and cilia organization. The dysregulation or mutation of septins has been implicated in cancer, neurodegenerative disease, and infertility, though therapeutic approaches directly targeting septins are at an early research stage[1][2][3][4][5][6]. No approved drugs currently target septins directly; their essential cellular roles present significant safety challenges for potential therapeutic intervention.

Other names
GTP-binding proteinP-Loop NTPaseSEPT1SEPT2SEPT3SEPT4SEPT5SEPT6SEPT7SEPT8SEPT9SEPT10SEPT11SEPT12SEPT14Cdc3Cdc10Cdc11Cdc12Shs1Spr3Spr28
02

Mechanism of action

No established mechanism for therapeutic agents; in principle, manipulation of septin filament assembly, GTPase activity, or protein-protein interactions may affect cell division and compartmentalization[1][2][4][5].

03

Biological functions

CytokinesisCell polarityCell compartmentalizationScaffold for protein localizationFormation of diffusion barrierCellular morphogenesisMembrane remodelingCilium/flagellum anchoring
04

Disease associations

CancerNeurodegenerative diseasesInfertilityPossibly infection and immune response (e.g., forming cages around pathogenic bacteria)
05

Safety considerations

Targeting septins may disrupt essential cell division processes across tissues.Septins are fundamental for cytoskeletal and membrane dynamics; inhibition could cause toxicity in proliferating cells, infertility, or neurotoxicity.
06

Interacting drugs

None established as direct regulators/inhibitors in clinical use; no well-characterized, clinically approved drugs directly targeting septins as of current knowledge[1][5].
07

Biomarkers

Elevated expression or mislocalization of specific septin isoforms (e.g., SEPT9) are investigated as cancer biomarkers (notably for colorectal cancer), but not broadly used across all septins[5].

Beyond the preview

Go deeper on Septin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Septin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call